Bayer Says BMS Is Core for Now, Eyes Higher Pharma Rank

Bayer is committed to its present portfolio, comprising Bayer Healthcare, Bayer CropScience, and Bayer MaterialScience (BMS), says Bayer’s new chairman Marijn Dekkers. “All three businesses are very important to us; all have very good market positions,” he says. Dekkers was responding to questions following Bayer’s 2010 results press briefing, held recently in Leverkusen. under new management: Marijn Dekkers (l), and new CFO Werner Baumann meeting the press at Leverkusen. The company may, however...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers